These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12413848)

  • 1. A novel class of endothelin-A receptor antagonists, (R)-2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-2H-chromene-3-carboxylic acids (S-1255). Conformational analysis of basic structure, crucial for ET(A) antagonism, in solution and solid states.
    Ishizuka N; Matsumura K; Kikuchi J; Nakai H
    Bioorg Med Chem; 2002 Dec; 10(12):3965-72. PubMed ID: 12413848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of a novel class of endothelin-A receptor antagonists and discovery of potent and selective receptor antagonist, 2-(benzo[1,3]dioxol-5-yl)-6-isopropyloxy-4-(4-methoxyphenyl)-2H-chromene-3-carboxylic acid (S-1255). 1. Study on structure-activity relationships and basic structure crucial for ET(A) antagonism.
    Ishizuka N; Matsumura K; Sakai K; Fujimoto M; Mihara S; Yamamori T
    J Med Chem; 2002 May; 45(10):2041-55. PubMed ID: 11985472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacologic characterization of S-1255, a highly potent and orally active endothelin A receptor antagonist.
    Iwasaki T; Mihara S; Shimamura T; Kawakami M; Masui M; Hayasaki-Kajiwara Y; Naya N; Ninomiya M; Fujimoto M; Nakajima M
    J Cardiovasc Pharmacol; 2001 Apr; 37(4):471-82. PubMed ID: 11300660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin receptor antagonist activity of (R)-(-)-2-(benzo[1,3]dioxol-5-yl)-N-(4-isopropylphenylsulfonyl)-2-(6-methyl- 2-propylpyridin-3-yloxy)acetamide hydrochloride (PABSA) in rat aortic smooth muscle cells and isolated rat thoracic aorta.
    Iwasaki T; Hayasaki-Kajiwara Y; Matsuo Y; Nakajima M
    Arzneimittelforschung; 2001; 51(7):529-34. PubMed ID: 11505783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethenesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.
    Harada H; Kazami J; Watanuki S; Tsuzuki R; Sudoh K; Fujimori A; Tanaka A; Tsukamoto S; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2001 May; 49(5):606-12. PubMed ID: 11383615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethenesulfonamide and ethanesulfonamide derivatives, a novel class of orally active endothelin-A receptor antagonists.
    Harada H; Kazami J; Watanuki S; Tsuzuki R; Sudoh K; Fujimori A; Sanagi M; Orita M; Nakahara H; Shimaya J; Tsukamoto S; Tanaka A; Yanagisawa I
    Bioorg Med Chem; 2001 Nov; 9(11):2955-68. PubMed ID: 11597477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyrrolidine-3-carboxylic acids as endothelin antagonists. 3. Discovery of a potent, 2-nonaryl, highly selective ETA antagonist (A-216546).
    Liu G; Henry KJ; Szczepankiewicz BG; Winn M; Kozmina NS; Boyd SA; Wasicak J; von Geldern TW; Wu-Wong JR; Chiou WJ; Dixon DB; Nguyen B; Marsh KC; Opgenorth TJ
    J Med Chem; 1998 Aug; 41(17):3261-75. PubMed ID: 9703472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of cyclic pentapeptide endothelin A receptor antagonists.
    Fukami T; Nagase T; Fujita K; Hayama T; Niiyama K; Mase T; Nakajima S; Fukuroda T; Saeki T; Nishikibe M
    J Med Chem; 1995 Oct; 38(21):4309-24. PubMed ID: 7473559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Activity relationships of 2-substituted 5,7-Diarylcyclopenteno[1,2-b]pyridine-6-carboxylic acids as a novel class of endothelin receptor antagonists.
    Niiyama K; Takahashi H; Nagase T; Kojima H; Amano Y; Katsuki K; Yamakawa T; Ozaki S; Ihara M; Yano M; Fukuroda T; Nishikibe M; Ishikawa K
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3041-5. PubMed ID: 12372497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent and selective non-benzodioxole-containing endothelin-A receptor antagonists.
    Tasker AS; Sorensen BK; Jae HS; Winn M; von Geldern TW; Dixon DB; Chiou WJ; Dayton BD; Calzadila S; Hernandez L; Marsh KC; WuWong JR; Opgenorth TJ
    J Med Chem; 1997 Jan; 40(3):322-30. PubMed ID: 9022798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzoxazines. II. Synthesis, conformational analysis, and structure--activity relationships of 3,4-dihydro-2H-1,4-benzoxazine-8-carboxamide derivatives as potent and long-acting serotonin-3 (5-HT3) receptor antagonists.
    Kuroita T; Marubayashi N; Sano M; Kanzaki K; Inaba K; Kawakita T
    Chem Pharm Bull (Tokyo); 1996 Nov; 44(11):2051-60. PubMed ID: 8945770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a novel bifunctional endothelin receptor antagonist, IRL 3630A, on guinea pig respiratory mechanics.
    Makatani M; Fujitani Y; Takimoto M; Oda K; Sasaki Y; Hori S; Inui T; Sakaki J; Okada T; Hoshiko K; Yamamura T
    Eur J Pharmacol; 2000 Oct; 406(1):139-47. PubMed ID: 11011045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigations of structural requirements for endothelin antagonism.
    van der Walle CF; Barlow DJ
    Curr Med Chem; 1998 Aug; 5(4):321-35. PubMed ID: 9668198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on haemodynamics by selective endothelin ET(B) receptor and combined endothelin ET(A)/ET(B) receptor antagonism during endotoxin shock.
    Wanecek M; Oldner A; Sundin P; Alving K; Weitzberg E; Rudehill A
    Eur J Pharmacol; 1999 Dec; 386(2-3):235-45. PubMed ID: 10618475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of PABSA, an orally active and highly potent endothelin-receptor antagonist.
    Iwasaki T; Mihara S; Shimamura T; Kawakami M; Hayasaki-Kajiwara Y; Naya N; Fujimoto M; Nakajima M
    J Cardiovasc Pharmacol; 1999 Jul; 34(1):139-47. PubMed ID: 10413080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 6-Carboxy-5,7-diarylcyclopenteno[1,2-b]pyridine derivatives: a novel class of endothelin receptor antagonists.
    Niiyama K; Mase T; Takahashi H; Naya A; Katsuki K; Nagase T; Ito S; Hayama T; Hisaka A; Ozaki S; Ihara M; Yano M; Fukuroda T; Noguchi K; Nishikibe M; Ishikawa K
    Bioorg Med Chem; 2002 Aug; 10(8):2461-70. PubMed ID: 12057635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin receptor antagonist triterpenoid, myriceric acid A, isolated from Myrica cerifera, and structure activity relationships of its derivatives.
    Sakurawi K; Yasuda F; Tozyo T; Nakamura M; Sato T; Kikuchi J; Terui Y; Ikenishi Y; Iwata T; Takahashi K; Konoike T; Mihara S; Fujimoto M
    Chem Pharm Bull (Tokyo); 1996 Feb; 44(2):343-51. PubMed ID: 8998841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective ET(A) antagonists. 5. Discovery and structure-activity relationships of phenoxyphenylacetic acid derivatives.
    Astles PC; Brown TJ; Halley F; Handscombe CM; Harris NV; Majid TN; McCarthy C; McLay IM; Morley A; Porter B; Roach AG; Sargent C; Smith C; Walsh RJ
    J Med Chem; 2000 Mar; 43(5):900-10. PubMed ID: 10715156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2,4-Diarylpyrrolidine-3-carboxylic acids--potent ETA selective endothelin receptor antagonists. 1. Discovery of A-127722.
    Winn M; von Geldern TW; Opgenorth TJ; Jae HS; Tasker AS; Boyd SA; Kester JA; Mantei RA; Bal R; Sorensen BK; Wu-Wong JR; Chiou WJ; Dixon DB; Novosad EI; Hernandez L; Marsh KC
    J Med Chem; 1996 Mar; 39(5):1039-48. PubMed ID: 8676339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hybrid peptides constructed from RES-701-1, an endothelin B receptor antagonist, and endothelin; binding selectivity for endothelin receptors and their pharmacological activity.
    Shibata K; Suzawa T; Ohno T; Yamada K; Tanaka T; Tsukuda E; Matsuda Y; Yamasaki M
    Bioorg Med Chem; 1998 Dec; 6(12):2459-67. PubMed ID: 9925302
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.